This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

5 Stocks With Big Insider Buying

Weatherford International has a market cap of $8.68 billion and an enterprise value of $17.10 billion. This stock trades at a cheap valuation, with a forward price-to-earnings of 10.71. Its estimated growth rate for this year is 2.9%, and for next year it's pegged at 47.2%. This is not a cash-rich company, since the total cash position on its balance sheet is $365 million and its total debt is a whopping $8.91 billion.

A vice president just bought 40,000 shares, or about $423,000 worth of stock, at $10.59 per share. Another vice president also just bought 20,000 shares, or about $217,000 worth of stock, at $10.88 per share.

From a technical perspective, WFT is currently trending above its 50-day moving average and below its 200-day moving average, which is neutral trendwise. This stock has been uptrending strongly for the last month and change, with shares soaring from a low of $8.84 to its recent high of $11.58 a share. During that uptrend, shares of WFT have been consistently making higher lows and higher highs, which is bullish technical price action. That move has now pushed WFT within range of triggering a near-term breakout trade.

If you're bullish on WFT, then I would look for long-biased trades if this stock manages to break out above some near-term overhead resistance levels at $11.41 to $11.77 a share with high volume. Look for a sustained move or close above those levels with volume that hits near or above its three-month average action of 10.6 million shares. If that breakout hits soon, then WFT will set up to re-test or possibly take out its next major overhead resistance levels at $12.47 to $12.56 a share. Any move above those levels will then put $12.92 to $13.50 into focus for shares of WFT.

Alexza Pharmaceuticals

One biotechnology and drugs player that insiders are jumping into here is Alexza Pharmaceuticals (ALXA - Get Report), which is focused on the research, development, and commercialization of novel proprietary products for the acute treatment of central nervous system conditions. Insiders are buying this stock into modest strength, since shares are up by 10.3% during the last six months.

Alexza Pharmaceuticals has a market cap of $78 million and an enterprise value $60 million. This stock trades at a premium valuation, with a price-to-sales of 14.86 and a price-to-book of 7.57. Its estimated growth rate for this year is 66.7%, and for next year it's pegged at 38%. This is a cash-rich company, since the total cash position on its balance sheet is $25.51 million and its total debt is $7.99 million. After you back out the debt, this company has $17.52 million of total cash on its books.
4 of 6

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free

Check Out Our Best Services for Investors

Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
SD $0.15 -11.76%
WFT $6.94 0.00%
AMRS $1.45 0.00%
ALXA $0.32 0.00%
PNY $59.09 0.00%


Chart of I:DJI
DOW 16,204.97 -211.61 -1.29%
S&P 500 1,880.05 -35.40 -1.85%
NASDAQ 4,363.1440 -146.4150 -3.25%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs